Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
First region outside the visible to be discovered and last to be utilized.
April 1, 2021
By: Gary E.
Contributing Writer
Near Infrared (NIR) Spectroscopy has become a mainstay in the pharmaceutical as well as most other industries as an analytical technique because of its rapid, non-destructive, and non-invasive sampling capabilities. With sufficient training in spectroscopy and Chemometrics, it is relatively easy to deploy at various points throughout the sample lifecycle for both qualitative and quantitative measurements. It was not always this way. Stories abound at the dawn of “modern” NIR in the 1970s of instruments purchased, people trained, samples obtained, and money allocated to fund ambitious projects using NIRS to solve problems quickly and cheaply—relative to a reference laboratory approach. Years later, these same instruments were mothballed, people lost their positions, and executives turned their nose up towards the technology because of these initial failed attempts at the outset. No doubt these initial failures were the result of educated scientists failing to do the first step of any new research: the literature search. If they had, they would have learned to appreciate and really understand the complexity and nuances of the NIR technique as compared to other spectroscopic modes. So that future analysts take heed of the philosopher George Santayana, who said, “Those who cannot remember the past are condemned to repeat it,” this article outlines and provides the critical elements gleaned from the history of NIR that should be paid attention to in order to be successful at applying the lessons learned from the past. Because the pharmaceutical industry is regulated, all analytical techniques used for pharmaceutical analysis are required to comply with CGMPs (Current Good Manufacturing Practices) in the U.S. and with other regulations in other countries. “cGMP regulations for drugs contain minimum requirements for the methods, facilities, and controls used in manufacturing, processing, and packing of a drug product. These regulations assure that a product is safe for use and that it has the ingredients and strength it claims to have.”1 The cGMP and similar requirements for analytical methods developed from NIR are found in many guidances across the globe.2,3,4,5,6,7 Their differences vary only slightly and for the most part follow the basic validation approaches for analytical methods used for pharmaceutical drug substance and product development because they have been harmonized through the International Council for Harmonization (ICH).8 NIR characteristics can be viewed as three legs of a triangle (Figure 1):
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !